Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUINACRINE vs QUIZARTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

QUINACRINE vs QUIZARTINIB: Safety Overview

Metric QUINACRINE QUIZARTINIB
Total FAERS Reports 123 357
Deaths Reported 5 61
Death Rate 4.1% 17.1%
Hospitalizations 29 121
Average Patient Age 48.8 yrs 54.0 yrs
% Female Patients 90.0% 57.9%
FDA Approval Date N/A Jul 20, 2023
Manufacturer N/A Daiichi Sankyo Inc.
Route N/A ORAL
Marketing Status N/A Prescription